Filed: 2/8/2023ACC: 0000950123-23-001109
π What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $74.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$74.42M
Total AUM (reported)
16.67M
Total Shares
Allocation by class
COMMON STOCK$58.49M78.6%
ORDINARY SHARES$15.93M21.4%
Portfolio Concentration
Top 3$51.39M69.1%
4β10$23.03M30.9%
Top 3 weight
69.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 16.67M
Sole
Full voting authority
16.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
Dyne Therapeutics, Inc.
SOLEShares2.22M
TypeSH
Market value$25.73M
34.58%
Sole
2.22M
Shared
0.00
None
0.00
Kinnate Biopharma, Inc.
SOLEShares2.21M
TypeSH
Market value$13.47M
18.10%
Sole
2.21M
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares3.93M
TypeSH
Market value$12.19M
16.38%
Sole
3.93M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$11.31M
15.20%
Sole
1.80M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$4.48M
6.02%
Sole
2.77M
Shared
0.00
None
0.00
LianBio
SOLEShares2.28M
TypeSH
Market value$3.74M
5.03%
Sole
2.28M
Shared
0.00
None
0.00
Praxis Precision Medicines, Inc.
SOLEShares1.47M
TypeSH
Market value$3.50M
4.70%
Sole
1.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc.SOLE | Common Stock | 2.22M | SH | $25.73M 34.58% | 2.22M | 0.00 | 0.00 |
Kinnate Biopharma, Inc.SOLE | Common Stock | 2.21M | SH | $13.47M 18.10% | 2.21M | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | Ordinary Shares | 3.93M | SH | $12.19M 16.38% | 3.93M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $11.31M 15.20% | 1.80M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $4.48M 6.02% | 2.77M | 0.00 | 0.00 |
LianBioSOLE | Ordinary Shares | 2.28M | SH | $3.74M 5.03% | 2.28M | 0.00 | 0.00 |
Praxis Precision Medicines, Inc.SOLE | Common Stock | 1.47M | SH | $3.50M 4.70% | 1.47M | 0.00 | 0.00 |